Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network

关节炎和肌肉骨骼疾病给世界人口带来了巨大且日益增长的负担。他们影响着28%的澳大利亚人（610万人）。在CRE基金的支持下，澳大利亚和新西兰肌肉骨骼（ANZMUSC）临床试验网络将通过高质量的合作临床研究、建立研究能力和有效地将研究成果转化为临床实践和卫生政策，来优化肌肉骨骼健康。

Arthritis and musculoskeletal conditions place an immense and growing burden on the world’s population. They affect 28% of Australians (>6.1 million people). With the support of CRE funding, the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network will optimise musculoskeletal health through high quality, collaborative clinical research, building research capacity and effective transfer of research outcomes into clinical practice and health policy.